Bone Densitometers Market Size, Share, Growth, Trends, and Global Industry Analysis: By Technique (Quantitative Ultrasound (QUS), Digital X-ray Radiogrammetry (DXR), Dual Energy X-ray Absorptiometry (DXA), Qualitative Computed Tomography(QCT), Peripheral DXA (pDXA), Others), By Site of Scanning (Spine, Forearm, Hip, Total Body, Others), By Applications (Osteoporosis, Post-Menopause, Hyperthyroidism, Bone Fractures, Rheumatoid Arthritis, Others), By End User (Orthopedic Clinic, Hospitals, Diagnostic centers), and Region Forecast 2019 - 2030

Bone Densitometers Market size was valued at US$ 286 million in 2023 and is poised to grow at a CAGR of 4.5% from 2024 - 2030. The increase in prevalence of osteoporosis due to rising incidence of vertebral and hip fractures increases exponentially with advancing age and metabolic diseases such as osteomalacia, growing obese population and increasing number of geriatric population are the major factors that are driving the growth of the bone densitometers market. Additionally, rising prevalence of osteoporosis in post-menopausal women are expected to fuel the growth of the market. Moreover, increasing number of awareness campaigns in the public pertaining to proper diagnosis and treatment of osteoporosis.

For instance, National Bone Health Alliance and Fracture Liaison Service (FLS) care coordination program is conducted by National Osteoporosis Foundation (NOF), a government healthcare organization for sharing a common prevention and awareness message among the masses. However, high cost and risks associated with the bone densitometers restrains the growth of the market over the future years. Bone Densitometry is an enhanced form of x-ray technology used to measure the bone loss by determining the bone mineral density (BMD). Bone densitometry is most commonly performed on lower spine and hips. Sometimes the whole body is scanned in children and adults. Rising geriatric population who are highly prone to the bone and muscle-related disorders and diseases like osteoarthritis and osteoporosis drives the market growth for bone densitometers.

Moreover, rising prevalence osteoporosis, osteoarthritis and post-menopausal complication also drives the growth of bone densitometers market. According to National Osteoporosis Foundation (NOF), it is expected that the number of cases with osteoporosis will exceed 61 Mn by 2020. According to National Spinal Cord Injury Centre in U.S, Researchers have assessed that in 2015, nearly 12,500 new spinal cord injuries have occurred in the year. Furthermore, rise in consumption of alcohol and smoking, growing innovations osteology field propels the growth of bone densitometers market. Increasing cost burden of equipment, high cost of the diagnosis, lack of skilled professionals, low reimbursement policies are hampering the growth of the bone densitometers market. 

Bone Densitometers Market Key Developments: 

• In November 2017, Medtronic plc received U.S.FDA approval to launch its Azure Pacemakers with BlueSyc technology in U.S.
• In March 2017, Biotronic launched its Smallest & Lightest MR-Conditional Pacemakers and a new range of quadripolar CRT-Pacemakers in Europe.